Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEPLAST-PED: Fibrinogen and PCC vs FFP in Infant Cardiac Surgery
NCT04434001Phase 2Terminated
- Sponsor
- Policlinico San Donato
- Start
- Feb 2020
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Fibrinogen human, prothrombin complex concentrate, human in postoperative hemorrhage, acquired fibrinogen deficiency (AFD), acquired coagulation factor deficiency, sponsored by Policlinico San Donato. Started Feb 2020; status: terminated.
02
Drugs
Fibrinogen humanprothrombin complex concentrate, human
03
Conditions
postoperative hemorrhageacquired fibrinogen deficiency (AFD)acquired coagulation factor deficiency
Beyond the preview
Go deeper on NCT04434001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434001.